The Michael J. Fox Foundation Partners with Cohen Veterans Bioscience on BRAIN Commons, Harnessing the Power of Big Data for Brain Diseases

The Michael J. Fox Foundation for Parkinson's Research (MJFF) and Cohen Veterans Bioscience announce their partnership on BRAIN Commons, a platform designed to fuel the use of big data in brain disease research. It provides unprecedented access to research data and analytics.

“Data sharing is critical to research discoveries,” says MJFF CEO Todd Sherer, PhD. “By including data across neurodegenerative diseases, BRAIN Commons facilitates research collaboration, data exploration, and reproducibility. The insights it creates will accelerate the development of new therapies for Parkinson’s and similar diseases.”

BRAIN Commons is tailored to brain research as its flexible data model accommodates a range of research data (e.g., neuroimaging, wearables/sensors, ‘omics). Researchers can visualize cohort trends, build data pipelines and run high-dimensional computations on all data types directly in the data commons. This dynamic workspace catalyzes hypothesis generation, data exploration, replication and validation.

The Michael J. Fox Foundation is joining the BRAIN Commons Membership Program and contributing standardized data across its research programs, including the Parkinson’s Progression Markers Initiative (PPMI), BioFIND, the LRRK2 Cohort Consortium, its digital health portfolio, and other Parkinson’s disease cohorts.

“The BRAIN Commons’ flexible and scalable graph-based data model enables us to partner with other Foundations that have their own high-quality curated and harmonized data, to share within and between disease areas, allowing for cross-cohort and cross-disease querying and analysis, thus maximizing the value of contributed data,” says Cohen Veterans Bioscience Chief Information Officer Lee Lancashire, PhD.

BRAIN Commons was launched and sponsored by Cohen Veterans Bioscience and co-developed with the Center for Data Intensive Science at the University of Chicago, which has launched three generations of data commons platforms.

View this press release on PR Newswire

About The Michael J. Fox Foundation for Parkinson’s Research

As the world’s largest nonprofit funder of Parkinson’s research, The Michael J. Fox Foundation is dedicated to accelerating a cure for Parkinson’s disease and improved therapies for those living with the condition today. The Foundation pursues its goals through an aggressively funded, highly targeted research program coupled with active global engagement of scientists, Parkinson’s patients, business leaders, clinical trial participants, donors and volunteers. In addition to funding more than $800 million in research to date, the Foundation has fundamentally altered the trajectory of progress toward a cure.

Operating at the hub of worldwide Parkinson’s research, the Foundation forges groundbreaking collaborations with industry leaders, academic scientists and government research funders; increases the flow of participants into Parkinson’s disease clinical trials with its online tool, Fox Trial Finder; promotes Parkinson’s awareness through high-profile advocacy, events and outreach; and coordinates the grassroots involvement of thousands of Team Fox members around the world. Learn more here

Share this article:

More from CVB

https://www.cohenveteransbioscience.org/wp-content/uploads/2023/03/what-is-post-traumatic-stress-disorder-ptsd-scaled.jpeg

Driving Progress: TBI Action Alliance Launches Multi-Pronged Initiative to Speed Development of Diagnostic and Therapeutic Solutions for Traumatic Brain Injury

https://www.cohenveteransbioscience.org/wp-content/themes/cvb-theme/assets/img/icon-news-card.png

A Message from CEO Peter Hoehn

https://www.cohenveteransbioscience.org/wp-content/themes/cvb-theme/assets/img/icon-news-card.png

CVB President Nicole Harmon, PhD Discusses How Traumatic Brain Injury Has Impacted Her Family

https://www.cohenveteransbioscience.org/wp-content/uploads/2024/01/bibi-C-3.jpg

Interview with Bibi Carmouche, BASE Jumper for 22 Jumps Camelback Mountain 2024

About Cohen Veterans Bioscience (CVB)

Cohen Veterans Bioscience is a non-profit 501(c)(3) biomedical research and technology organization dedicated to advancing brain health by fast-tracking precision diagnostics and tailored therapeutics.

For Media Inquiries

Please feel free to email us at media@cohenbio.org